A profitable Indian company with a few clean years behind it now faces a choice that barely existed a decade ago. It can list on the SME board and raise funds from the public, or it can run a Series B and take a single large cheque from a growth investor. Most advice still files these under separate headings, the SME IPO for established manufacturers and the Series B for venture-backed technology firms. That split has aged badly.
For a founder generating a crore or more of annual operating profit, the real question is not which camp the business belongs to. It is what the cap table, the boardroom, and the compliance calendar should look like five years from now. An SME IPO and a Series B can put similar sums in the bank. They share almost nothing else.
What Each Route Actually Puts on the Table
An SME IPO lists the company on the NSE Emerge or BSE SME platform and sells fresh shares to public investors. Since the ICDR Regulations were tightened in 2025, an issuer must show operating profit of at least Rs 1 crore in two of the three preceding financial years, a test that replaced the older net-worth route under which loss-making companies could still qualify. Post-issue paid-up capital sits at or below Rs 10 crore for the core SME route, with issuers up to Rs 25 crore also eligible. The money arrives from a wide pool of applicants, with at least 200 allottees required.
A Series B is the second major institutional equity round, aimed at companies that have proven a repeatable model. In India, these rounds typically run between Rs 80 crore and Rs 400 crore, with founder dilution of roughly 15 to 20 per cent. The capital comes from one or a handful of growth funds, and it almost always takes the form of convertible preferred shares rather than ordinary equity. That single structural detail shapes everything that follows.
Dilution, and Who Really Controls the Company
Here, the comparison turns sharp. A Series B lead does not simply buy shares. It negotiates a board seat, protective provisions over key decisions and a liquidation preference that pays the investor first if the company is ever sold. A founder can hold a majority of the equity after a Series B and still find that hiring a chief financial officer, approving a budget or selling the business needs an investor’s consent.
An SME IPO dilutes ownership too, but the buyers are dispersed and largely passive. No single public shareholder sits across the table demanding veto rights. What the founder gives up instead is privacy and a measure of day-to-day freedom: audited quarterly results, disclosure obligations and public scrutiny of every material decision. Both are real trades, but they are different trades. One hands influence to a single sophisticated counterparty. The other spreads it thinly across the market.
How the Price Gets Set, and Whether the Money Shows Up
Series B valuations are negotiated behind closed doors, and in the current climate, that negotiation has become harder. Only about 30 to 40 per cent of companies that raise a Series A go on to close a Series B, and growth investors have grown selective about backing anything short of clean unit economics. A term sheet can take months and still fall through.
An SME IPO is priced by the market rather than a single fund, which cuts both ways. A strong book can deliver a valuation a private investor would never underwrite; a weak market can force a company to shelve the plan. SEBI has added flexibility here: under an April 2026 circular, issuers may revise the size of a fresh issue by as much as 50 percent without refiling the offer document for issues opening on or before 30 September 2026. The SME segment itself has cooled from its peak, with about 105 companies raising roughly Rs 5,121 crore on the NSE Emerge platform in FY26 to date, down about a quarter year on year, even as the average issue size climbed to around Rs 50 crore. A thinner market rewards genuinely strong businesses and punishes marginal ones. This is where advisory judgment earns its place and where a firm like Lorvet will pressure-test whether the market can support the number a founder has in mind before the company commits to the cost of a public process.
The Obligations Each Choice Leaves Behind
Going public is not a one-time event. A listed SME carries continuous compliance: quarterly financial reporting, minimum public shareholding rules, promoter lock-ins, and related-party transaction norms that now extend to SME-listed entities, with materiality set at 10 per cent of turnover or Rs 50 crore, whichever is lower. Issues above Rs 50 crore also need a monitoring agency to track the use of proceeds. None of it is fatal, but it is permanent and it carries a cost.
A Series B leaves a different residue. The company takes on information rights, reserved matters, and reporting to a lead investor, along with an implicit clock. Preferred capital expects a return, which means another round or an exit within a defined horizon. The founder who raises a Series B has, in effect, agreed to keep raising or to sell. That expectation rarely appears in the term sheet in plain words, but it governs the years that follow.
When a Series B Is Still the Right Call
For all that, the equity round wins in several situations, and pretending otherwise would be dishonest. A company that is not yet profitable cannot clear the Rs 1 crore operating-profit test and has no SME IPO route open to it, so for pre-profit businesses chasing rapid scale, the question is moot. Where a founder needs a specific investor’s network, sector expertise, or follow-on capacity, a single committed partner can be worth more than a spread of passive shareholders. And where the capital required runs well beyond what the SME board will comfortably absorb, private growth money can write a bigger cheque with less market risk.
The Series B is the better instrument for the company that intends to keep scaling hard and is comfortable staying on the venture treadmill. Mapping that trajectory honestly, before either process starts, is the kind of groundwork Lorvet works through with founders.
Choosing the Route That Fits the Founder
The decision is less about the amount raised than about the kind of company a founder wants to run. A profitable SME that values control, wants a public currency for future acquisitions and can absorb the compliance load will often find the SME IPO the stronger fit. A high-growth business that needs a strategic partner and more capital than the public SME market will bear is better served by a Series B, dilution and governance strings included.
Neither is a default. Get the framing right, and the choice between an SME IPO and a Series B stops being a leap in the dark and becomes a decision a founder can defend for years. That framing, built on the real numbers, is where an advisory relationship with a firm such as Lorvet does its quiet work.
Frequently Asked Questions
1.Can a profitable SME choose between an SME IPO and a Series B, or is one ruled out?
A profitable SME generating at least Rs 1 crore of operating profit in two of the last three years can genuinely consider both, which is what makes the decision real rather than academic. A pre-profit company cannot clear the SME IPO eligibility test, so for it, the Series B is the only equity route. The choice exists precisely because the business is already making money.
2.How much dilution does each route involve?
A Series B typically dilutes founders by roughly 15 to 20 per cent, concentrated in the hands of one or a few funds that also negotiate board seats and control rights. An SME IPO dilutes ownership across a wide base of passive public shareholders, so the percentage sold varies with the issue but no single buyer gains veto power. The headline dilution can look similar; the control consequences are very different.
3.Which route values the company higher?
Neither is reliably higher. A Series B valuation is negotiated privately and depends heavily on the investor’s view of your unit economics. An SME IPO is priced by the market, so a strong book can beat what any single fund would offer, while a weak market can undershoot it. The right answer depends on the strength of the business and the state of the market at the time.
4.What ongoing obligations come with an SME listing?
A listed SME faces continuous compliance: quarterly financial reporting, minimum public shareholding rules, promoter lock-ins and related-party transaction norms with materiality set at 10 per cent of turnover or Rs 50 crore, whichever is lower. Issues above Rs 50 crore also require a monitoring agency to track use of proceeds. These obligations are permanent and carry real cost, which should be weighed before listing.
5.Is it harder to raise a Series B than to complete an SME IPO right now?
Both have tightened. Only about 30 to 40 per cent of Series A companies go on to close a Series B, and investors are selective about unit economics, so a term sheet can take months and still collapse. The SME market has cooled too, with FY26 fundraising down about a quarter year on year, meaning a weak book can force a company to shelve its issue. Each route rewards a genuinely strong business and punishes a marginal one.
